aminoglutethimide /ami·no·glu·teth·i·mide/ (-gloo-teth´ĕ-mīd) an inhibitor of cholesterol metabolism, thereby reducing adrenocortical steroid synthesis; used in the treatment of Cushing's syndrome. It also inhibits estrogen production from androgens in peripheral tissue.
aminoglutethimide (
mē´nōglōōteth´mīd),
aminoglutethimide
aminoglutethimide (
mē´nōglōōteth´mīd),n brand name: Cytadren;
drug class: antineoplastic, adrenal steroid inhibitor;
action: acts by inhibiting the enzymatic conversion of cholesterol to pregnenolone, thereby blocking synthesis of all adrenal steroids;
uses: suppression of adrenal function in Cushing's syndrome, metastatic breast cancer, and adrenal cancer.
drug class: antineoplastic, adrenal steroid inhibitor;
action: acts by inhibiting the enzymatic conversion of cholesterol to pregnenolone, thereby blocking synthesis of all adrenal steroids;
uses: suppression of adrenal function in Cushing's syndrome, metastatic breast cancer, and adrenal cancer.
aminoglutethimide
a compound that inhibits the adrenal cortex and peripheral aromatase, thereby blocking production of adrenal steroids. Used in the treatment of hyperadrenocorticism.
aminoglutethimide
Oncology A nonsteroidal aromatase inhibitor which inhibits estrogen production and suppresses estrogen-dependent tumor growth. See Estrogen-receptor.
How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content.
| ?Page tools | ||
|---|---|---|
|